Solbar Ningbo Protein Technology Co., Ltd.
Solbar Ningbo Protein Technology Co., Ltd. engages in the research and development, production, and sale of soybean protein products in China and internationally. It offers functional and textured soy protein concentrates, textured soy proteins, textured fibrous vegetable proteins, isolated soy proteins, defatted soy flours, and non-GMO soybean oil, which are widely used in food, health products,… Read more
Solbar Ningbo Protein Technology Co., Ltd. (603231) - Total Liabilities
Latest total liabilities as of September 2025: CN¥210.14 Million CNY
Based on the latest financial reports, Solbar Ningbo Protein Technology Co., Ltd. (603231) has total liabilities worth CN¥210.14 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Solbar Ningbo Protein Technology Co., Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Solbar Ningbo Protein Technology Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Solbar Ningbo Protein Technology Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of Solbar Ningbo Protein Technology Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
USA | $102.49 Million |
|
Curacle Co. Ltd.
KQ:365270
|
Korea | ₩16.67 Billion |
|
NEXCOM International Co Ltd
TWO:8234
|
Taiwan | NT$2.75 Billion |
|
I-PEX Inc.
OTCGREY:DAIKF
|
USA | $34.10 Billion |
|
The Lion Electric Company
PINK:LEVWQ
|
USA | $499.77 Million |
|
295310
KQ:295310
|
Korea | ₩53.75 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Solbar Ningbo Protein Technology Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Solbar Ningbo Protein Technology Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Solbar Ningbo Protein Technology Co., Ltd. (2019–2024)
The table below shows the annual total liabilities of Solbar Ningbo Protein Technology Co., Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥210.23 Million | -13.33% |
| 2023-12-31 | CN¥242.56 Million | -29.14% |
| 2022-12-31 | CN¥342.29 Million | +19.55% |
| 2021-12-31 | CN¥286.31 Million | +140.72% |
| 2020-12-31 | CN¥118.94 Million | -41.28% |
| 2019-12-31 | CN¥202.54 Million | -- |